Table 3. Comparisons of the clinicopathologic findings between the metachronous and control groups in patients with carcinoma.

Values are presented as mean±standard deviation or number (%).

^*Background mucosal pathologies, such as atrophy and intestinal metaplasia, were evaluated endoscopically.